No Data
TIM is set to receive approximately 344 million yen in Dividends, and the pipeline will also begin clinical trials in the United States.
TIM Corporation <4891> announced that after the close of Trade on February 6, it received a dividend notification from CORXEL Pharmaceuticals Limited (formerly Ji Xing Pharmaceuticals, hereinafter referred to as "CORXEL"), and plans to record $2,254,924.56 (US dollars, approximately 344 million yen, converted at 1 US dollar = 152.61 yen) as non-operating income from received Dividends. CORXEL is a global life sciences-focused investment firm.
Individual stock information.
ExaWiz <4259.T> has risen for the fourth consecutive day. The Ministry of Health, Labour and Welfare approved on the 6th the designation policy for priority review of the program medical device that is being developed by its 100% subsidiary ExaMD, which diagnoses dementia through free conversation voice using Artificial Intelligence (AI) Medical Devices. TIM <4891.T> saw a significant increase. The company received a notice of Dividends from Corxel Pharmaceuticals, in which it owns Stocks. The amount of Dividends is approximately 2,254,924 dollars (about 344 million yen).
Growth 250 has risen for four consecutive days, Drone-related stocks are popular = Emerging Markets, 7th.
The TSE Growth Market 250 Index has risen for four consecutive days. The market's preference for Emerging Markets continues, rising in contrast to the Main Board. Companies such as Synspective<290A.T>, ABEDIA<5574.T>, and TIM<4891.T> have seen increases. The popularity of Drone-related stocks like Terra Drone<278A.T> and Liberaware<218A.T> was also prominent. In the JASDAQ, McDonald's Holdings Japan<2702.T> remains strong. Provided by Well.
Express News | [Change Report] Nissay Capital reports a decrease in its Shareholding ratio of TIMS (4891.JP) to 3.66%.
Volume change rate ranking (9 o'clock hour) - Data SEC, Nichicon, etc. are ranked.
In the volume change rate ranking, comparing the average volume over the last five days with the volume on the day of distribution allows insight into market participants' interests, such as trends in stock selection. ■ Top volume change rates [As of February 7, 9:32] (Compared to the average volume over the last five days) Stock Code Stock Name Volume Average Volume over 5 Days Volume Change Rate Stock Price Change Rate <3666> Technos JPN 2641000 107185.08 341.89% 0.015% <4591> Rebo
Lear Gate, Ribomic and others.
＜2385＞ The subsidiary NRL Pharma of General Medical Research Institute has obtained a patent. ＜4591＞ Announcement regarding the success of the low-dose group in the Phase II clinical trial of the drug for treating achondroplasia (umedaptanib pegol) at the Ribomic Fusion Conference 2025. ＜4592＞ The second manufacturing results related to the approval conditions for the shipping of Sun Bio Acugo for intracranial transplantation. ＜4891＞ Regarding TIM's TMS-007 (JX10).